- Home
- WHLR vs SILO Comparison
WHLR vs SILO Comparison
Compare WHLR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | SILO |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Apparel |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.5M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | WHLR | SILO |
|---|---|---|
| Price | $5.53 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 146.2K | ★ 154.2K |
| Earning Date | 03-03-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 184.08 | N/A |
| Revenue | ★ $101,834,000.00 | $72,102.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.03 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.70 | $0.33 |
| 52 Week High | $9,114.01 | $2.09 |
Technical Indicators
Market Signals| Indicator | WHLR | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 72.15 | 43.65 |
| Support Level | $1.59 | $0.35 |
| Resistance Level | $6.40 | $0.39 |
| Average True Range (ATR) | 0.41 | 0.02 |
| MACD | 0.50 | 0.00 |
| Stochastic Oscillator | 83.14 | 23.01 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.